Keith Orford
Director/Board Member bij CALITHERA BIOSCIENCES, INC.
Vermogen: 1 $ op 31-03-2024
Profiel
Dr. Keith Orford is a Chief Medical Officer, Executive VP-Clinical at Fog Pharmaceuticals, Inc. He is on the Board of Directors at Calithera Biosciences, Inc. He received his doctorate degree from Georgetown University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2023 | 54 ( 0.00% ) | 1 $ | 31-03-2024 |
Actieve functies van Keith Orford
| Bedrijven | Functie | Begin |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 05-11-2021 |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01-11-2021 |
Opleiding van Keith Orford
| Georgetown University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
